Abstract
This chapter focuses on the main new drug development strategies using the fragment-based drug design (FBDD) approach and its relationship with high-throughput screening (HTS) methods. Different methods of building fragment libraries and methods for identifying potential sites of interaction in macromolecules are discussed. A discussion about the experimental techniques useful in FBDD, such as nuclear magnetic resonance, surface plasmon resonance, X-ray crystallography, thermal shift assay, isothermal titration calorimetry and mass spectrometry, also makes it possible to understand the potential of this way of searching for new candidates for bioactive compounds.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aggarwal R, Gupta A, Chelur V et al (2021) DeepPocket: ligand binding site detection and segmentation using 3D convolutional neural networks. J Chem Inf Model 62:5069. https://doi.org/10.1021/ACS.JCIM.1C00799/ASSET/IMAGES/LARGE/CI1C00799_0007.JPEG
Allen KN, Bellamacina CR, Ding X et al (1996) An experimental approach to mapping the binding surfaces of crystalline proteins. J Phys Chem 100:2605–2611. https://doi.org/10.1021/jp952516o
Andola P, Pagag J, Laxman D, Guruprasad L (2022) Fragment-based inhibitor design for SARS-CoV2 main protease. Struct Chem 33:1467–1487. https://doi.org/10.1007/S11224-022-01995-Z
Atobe M (2020) Fragment-based design of isoquinoline derivatives as anti-inflammatory drugs. Research Outreach. https://researchoutreach.org/articles/fragment-based-design-isoquinoline-derivatives-anti-inflammatory-drugs/. Accessed 21 Sep 2022.
Bakhtiar R (2013) Surface plasmon resonance spectroscopy: a versatile technique in a biochemist’s toolbox. J Chem Educ 90:203–209. https://doi.org/10.1021/ED200549G/ASSET/IMAGES/LARGE/ED-2011-00549G_0006.JPEG
Bartolowits M, Davisson VJ (2016) Considerations of protein subpockets in fragment-based drug design. Chem Biol Drug Des 87:5–20. https://doi.org/10.1111/CBDD.12631
Bataille CJR, Rabbitts TH, Claridge TDW (2020) NMR waterLOGSY as an assay in drug development programmes for detecting protein-ligand interactions–NMR waterLOGSY. Bio-protocol 10:e3666. https://doi.org/10.21769/BioProtoc.3666
Becker W, Bhattiprolu KC, Gubensäk N, Zangger K (2018) Investigating protein–ligand interactions by solution nuclear magnetic resonance spectroscopy. ChemPhysChem 19:895–906. https://doi.org/10.1002/CPHC.201701253
Bemis GW, Murcko MA (1996) The properties of known drugs. 1. Molecular frameworks. J Med Chem 39:2887–2893. https://doi.org/10.1021/JM9602928/ASSET/IMAGES/LARGE/JM9602928FB10A.JPEG
Benmansour F, Trist I, Coutard B et al (2017) Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design. Eur J Med Chem 125:865–880. https://doi.org/10.1016/J.EJMECH.2016.10.007
Berman HM, Westbrook J, Feng Z et al (2000) The protein data bank. Nucleic Acids Res 28:235–242. https://doi.org/10.1093/NAR/28.1.235
Brown N (2016) In silico medicinal chemistry. The Royal Society of Chemistry, Cambridge
Chan DSH, Whitehouse AJ, Coyne AG, Abell C (2017) Mass spectrometry for fragment screening. Essays Biochem 61:465–473. https://doi.org/10.1042/EBC20170071
Clore GM, Gronenborn AM (1983) Theory of the time dependent transferred nuclear Overhauser effect: applications to structural analysis of ligand-protein complexes in solution. J Magn Reson 53:423–442. https://doi.org/10.1016/0022-2364(83)90215-9
Coley CW, Rogers L, Green WH, Jensen KF (2018) SCScore: synthetic complexity learned from a reaction corpus. J Chem Inf Model 58:252–261
Congreve MS, Davis DJ, Devine L et al (2003) Detection of ligands from a dynamic combinatorial library by X-ray crystallography. Angew Chem Int Ed 42:4479. https://doi.org/10.1002/anie.200351951
Cosgrove BD, Gilbert PM, Porpiglia E et al (2014) Rejuvenation of the muscle stem cell population restores strength to injured aged muscles. Nat Med 20:255. https://doi.org/10.1038/nm.3464
Coutard B, Decroly E, Li C et al (2014) Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery. Antiviral Res 106:61–70. https://doi.org/10.1016/J.ANTIVIRAL.2014.03.013
Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 71(7):1–13. https://doi.org/10.1038/srep42717
Dallakyan S, Olson AJ (2015) Small-molecule library screening by docking with PyRx. Methods Mol Biol 1263:243–250. https://doi.org/10.1007/978-1-4939-2269-7_19
Dalvit C, Fogliatto GP, Stewart A et al (2001) WaterLOGSY as a method for primary NMR screening: Practical aspects and range of applicability. J Biomol NMR 21:349. https://doi.org/10.1023/A:1013302231549
Damian L (2013) Isothermal titration calorimetry for studying protein-ligand interactions. Methods Mol Biol 1008:103–118. https://doi.org/10.1007/978-1-62703-398-5_4/COVER
Ding Y, Tang J, Guo F (2017) Identification of protein-ligand binding sites by sequence information and ensemble classifier. J Chem Inf Model 57:3149–3161. https://doi.org/10.1021/ACS.JCIM.7B00307/ASSET/IMAGES/LARGE/CI-2017-003074_0005.JPEG
Drews J (2000) Drug discovery: a historical perspective. Science 287:1960
Drinkwater N, Vu H, Lovell KM et al (2010) Fragment-based screening by X-ray crystallography, MS and isothermal titration calorimetry to identify PNMT (phenylethanolamine N-methyltransferase) inhibitors. Biochem J 431:51–61. https://doi.org/10.1042/BJ20100651
Durdagi S, Mavromoustakos T, Chronakis N, Papadopoulos MG (2008) Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations. Bioorg Med Chem 16:9957–9974. https://doi.org/10.1016/J.BMC.2008.10.039
Edelsbrunner H (1995) The union of balls and its dual shape. Discret Comput Geom 133(13):415–440. https://doi.org/10.1007/BF02574053
Edelsbrunner H, Shah NR (1996) Incremental topological flipping works for regular triangulations. Algorithmica 153(15):223–241. https://doi.org/10.1007/BF01975867
Eisen MB, Wiley DC, Karplus M, Hubbard RE (1994) HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site. Proteins 19:199–221. https://doi.org/10.1002/PROT.340190305
Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43:3714–3717. https://doi.org/10.1021/JM000942E/SUPPL_FILE/JM000942E_S.PDF
Facello MA (1995) Implementation of a randomized algorithm for Delaunay and regular triangulations in three dimensions. Comput Aided Geom Des 12:349–370. https://doi.org/10.1016/0167-8396(94)00018-N
Fejzo J, Lepre CA, Peng JW et al (1999) The SHAPES strategy: an NMR-based approach for lead generation in drug discovery. Chem Biol 6:755–769. https://doi.org/10.1016/S1074-5521(00)80022-8
Feyfant E, Cross JB, Paris K, Tsao DHH (2011) Fragment-based drug design. Methods Mol Biol 685:241–252. https://doi.org/10.1007/978-1-60761-931-4_12
Fitzpatrick PA, Steinmetz ACU, Ringe D, Klibanov AM (1993) Enzyme crystal structure in a neat organic solvent. Proc Natl Acad Sci U S A 90:8653. https://doi.org/10.1073/pnas.90.18.8653
Frei P, Hevey R, Ernst B (2019) Dynamic combinatorial chemistry: a new methodology comes of age. Chem A Eur J 25:60
Grädler U, Schwarz D, Blaesse M et al (2019) Discovery of novel cyclophilin D inhibitors starting from three dimensional fragments with millimolar potencies. Bioorg Med Chem Lett 29:126717. https://doi.org/10.1016/J.BMCL.2019.126717
Greenberg WA, Priestley ES, Sears PS et al (1999) Design and synthesis of new aminoglycoside antibiotics containing neamine as an optimal core structure: correlation of antibiotic activity with in vitro inhibition of translation. J Am Chem Soc 121:6527–6541. https://doi.org/10.1021/JA9910356/ASSET/IMAGES/LARGE/JA9910356F00007.JPEG
Groom CR, Bruno IJ, Lightfoot MP, Ward SC (2016) The Cambridge structural database. Acta Crystallogr Sect B Struct Sci Cryst Eng Mater 72:171. https://doi.org/10.1107/S2052520616003954
Guedes IA, de Magalhaes CS, Dadenne LE (2014) Receptor-ligand molecular docking. Biophys Rev 6:75–87
Hajduk PJ (2006) Fragment-based drug design: How big is too big? J Med Chem 49:6972–6976. https://doi.org/10.1021/JM060511H/SUPPL_FILE/JM060511HSI20061002_015718.PDF
Hajduk PJ, Boyd S, Nettesheim D et al (2000) Identification of novel inhibitors of urokinase via NMR-based screening. J Med Chem 43:3862–3866. https://doi.org/10.1021/JM0002228
Hajduk PJ, Huth JR, Fesik SW (2005) Druggability indices for protein targets derived from NMr-based screening data. J Med Chem 48:2518. https://doi.org/10.1021/jm049131r
Hajduk PJ, Olejniczak ET, Fesik SW (1997) One-dimensional relaxation- and diffusion-edited NMR methods for screening compounds that bind to macromolecules. J Am Chem Soc 119:12257. https://doi.org/10.1021/ja9715962
Hann MM, Leach AR, Harper G (2001) Molecular complexity and its impact on the probability of finding leads for drug discovery. J Chem Inf Comput Sci 41:856–864. https://doi.org/10.1021/CI000403I
Hao GF, Jiang W, Ye YN et al (2016) ACFIS: a web server for fragment-based drug discovery. Nucleic Acids Res 44:W550–W556. https://doi.org/10.1093/NAR/GKW393
Harborne JB (1995) Dictionary of natural products. Phytochemistry 38:279. https://doi.org/10.1016/0031-9422(95)90037-3
Hearty S, Conroy PJ, Ayyar BV et al (2010) Surface plasmon resonance for vaccine design and efficacy studies: recent applications and future trends. Expert Rev Vaccines 9:645–664. https://doi.org/10.1586/ERV.10.52
Hernandez M, Ghersi D, Sanchez R (2009) SITEHOUND-web: a server for ligand binding site identification in protein structures. Nucleic Acids Res 37:W413–W416. https://doi.org/10.1093/NAR/GKP281
Hess B, Kutzner C, Van Der Spoel D, Lindahl E (2008) GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 4:435–447. https://doi.org/10.1021/CT700301Q/ASSET/IMAGES/LARGE/CT700301QF00006.JPEG
Hopkins AL, Groom CR, Alex A (2004) Ligand efficiency: a useful metric for lead selection. Drug Discov Today 9:430
Jacquemard C, Kellenberger E (2019) A bright future for fragment-based drug discovery: what does it hold? Expert Opin Drug Discov 14:413–416. https://doi.org/10.1080/17460441.2019.1583643
Jason-Moller L, Murphy M, Bruno JA (2006) Overview of Biacore systems and their applications. Curr Protoc protein Sci Chapter 19:Unit 19.13. https://doi.org/10.1002/0471140864.PS1913S45
Jencks WP (1981) On the attribution and additivity of binding energies. Proc Natl Acad Sci U S A 78:4046–4050
Jordan RA, El-Manzalawy Y, Dobbs D, Honavar V (2012) Predicting protein-protein interface residues using local surface structural similarity. BMC Bioinformatics 13:41. https://doi.org/10.1186/1471-2105-13-41
Joseph-McCarthy D, Campbell AJ, Kern G, Moustakas D (2014) Fragment-based lead discovery and design. J Chem Inf Model 54:693–704. https://doi.org/10.1021/CI400731W/ASSET/IMAGES/LARGE/CI-2013-00731W_0005.JPEG
Jung LS, Shumaker-Parry JS, Campbell CT et al (2000) Quantification of tight binding to surface-immobilized phospholipid vesicles using surface plasmon resonance: Binding constant of phospholipase A2. J Am Chem Soc 122:4177–4184. https://doi.org/10.1021/JA993879V/ASSET/IMAGES/MEDIUM/JA993879VE00002.GIF
Katsila T, Spyroulias GA, Patrinos GP, Matsoukas MT (2016) Computational approaches in target identification and drug discovery. Comput Struct Biotechnol J 14:177–184. https://doi.org/10.1016/J.CSBJ.2016.04.004
Khan SA, Zia K, Ashraf S et al (2021) Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. J Biomol Struct Dyn 39:2607–2616. https://doi.org/10.1080/07391102.2020.1751298
Kirsch P, Hartman AM, Hirsch AKH, Empting M (2019) Concepts and core principles of fragment-based drug design. Molecules 24:4309. https://doi.org/10.3390/MOLECULES24234309
Kirshner DA, Nilmeier JP, Lightstone FC (2013) Catalytic site identification—a web server to identify catalytic site structural matches throughout PDB. Nucleic Acids Res 41:W256. https://doi.org/10.1093/NAR/GKT403
Klein J, Heal JR, Hamilton WDO et al (2014) Yeast synthetic biology platform generates novel chemical structures as scaffolds for drug discovery. ACS Synth Biol 3:314. https://doi.org/10.1021/sb400177x
Knehans T, Schüller A, Doan DN et al (2011) Structure-guided fragment-based in silico drug design of dengue protease inhibitors. J Comput Aided Mol Des 25:263–274. https://doi.org/10.1007/S10822-011-9418-0
Krivák R, Hoksza D (2018) P2Rank: machine learning based tool for rapid and accurate prediction of ligand binding sites from protein structure. J Cheminform 10:1–12. https://doi.org/10.1186/S13321-018-0285-8/TABLES/4
Kuroki K, Maenaka K (2011) Analysis of receptor-ligand interactions by surface plasmon resonance. Methods Mol Biol 748:83–106. https://doi.org/10.1007/978-1-61779-139-0_6/COVER
Lauri G, Bartlett PA (1994) CAVEAT: a program to facilitate the design of organic molecules. J Comput Aided Mol Des 8:51–66. https://doi.org/10.1007/BF00124349
Laurie ATR, Jackson RM (2005) Q-SiteFinder: an energy-based method for the prediction of protein–ligand binding sites. Bioinformatics 21:1908–1916. https://doi.org/10.1093/BIOINFORMATICS/BTI315
Leach AR, Hann MM (2011) Molecular complexity and fragment-based drug discovery: ten years on. Curr Opin Chem Biol 15:489–496. https://doi.org/10.1016/J.CBPA.2011.05.008
Leavitt S, Freire E (2001) Direct measurement of protein binding energetics by isothermal titration calorimetry. Curr Opin Struct Biol 11:560–566. https://doi.org/10.1016/S0959-440X(00)00248-7
Lin Y, Yoo S, Sanchez R (2012) SiteComp: a server for ligand binding site analysis in protein structures. Bioinformatics 28:1172. https://doi.org/10.1093/BIOINFORMATICS/BTS095
Liu M, Quinn RJ (2019) Fragment-based screening with natural products for novel anti-parasitic disease drug discovery. Expert Opin Drug Discov 14:1283–1295. https://doi.org/10.1080/17460441.2019.1653849/SUPPL_FILE/IEDC_A_1653849_SM2190.XLSX
Lo MC, Aulabaugh A, Jin G et al (2004) Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. Anal Biochem 332:153–159. https://doi.org/10.1016/J.AB.2004.04.031
Lotfi Shahreza M, Ghadiri N, Green JR (2020) A computational drug repositioning method applied to rare diseases: adrenocortical carcinoma. Sci Rep 101(10):1–7. https://doi.org/10.1038/s41598-020-65658-x
Luque I, Freire E (2000) The structural stability of binding sites. Consequences for binding affinity and cooperativity. Proteins 4:63–71
Lyu J, Irwin JJ, Roth BL et al (2019) Ultra-large library docking for discovering new chemotypes. Nature 566:224
Magsumov T, Ziying L, Sedov I (2020) Comparative study of the protein denaturing ability of different organic cosolvents. Int J Biol Macromol 160:880–888. https://doi.org/10.1016/J.IJBIOMAC.2020.05.260
Makhija MT, Kasliwal RT, Kulkarni VM, Neamati N (2004) De novo design and synthesis of HIV-1 integrase inhibitors. Bioorg Med Chem 12:2317–2333. https://doi.org/10.1016/J.BMC.2004.02.005
Marchand JR, Caflisch A (2018) In silico fragment-based drug design with SEED. Eur J Med Chem 156:907–917
Mashalidis EH, Śledå P, Lang S, Abell C (2013) A three-stage biophysical screening cascade for fragment-based drug discovery. Nat Protoc 811(8):2309–2324. https://doi.org/10.1038/nprot.2013.130
Matricon P, Suresh RR, Gao ZG et al (2021) Ligand design by targeting a binding site water. Chem Sci 12:960. https://doi.org/10.1039/d0sc04938g
McGreig JE, Uri H, Antczak M et al (2022) 3DLigandSite: structure-based prediction of protein–ligand binding sites. Nucleic Acids Res 50:W13–W20. https://doi.org/10.1093/NAR/GKAC250
McPherson A, Cudney B (2014) Optimization of crystallization conditions for biological macromolecules. Acta Crystallogr Sect F Struct Biol Commun 70:1445. https://doi.org/10.1107/S2053230X14019670
Miranker A, Karplus M (1991) Functionality maps of binding sites: a multiple copy simultaneous search method. Proteins 11:29–34. https://doi.org/10.1002/PROT.340110104
Morita A, Ochi S, Satoh H et al (2021) A novel RNA synthesis inhibitor, STK160830, has negligible DNA-intercalating activity for triggering a p53 response, and can inhibit p53-dependent apoptosis. Life 11:1087. https://doi.org/10.3390/LIFE11101087/S1
Morris GM, Ruth H, Lindstrom W et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785. https://doi.org/10.1002/JCC.21256
Nakamura CE, Abeles RH (1985) Mode of interaction of beta-hydroxy-beta-methylglutaryl coenzyme A reductase with strong binding inhibitors: compactin and related compounds. Biochemistry 24:1364–1376
Ni F (1994) Recent developments in transferred NOE methods. Prog Nucl Magn Reson Spectrosc 26:517
Oliveira AM (2022) Quantitative structure-activity relationships (QSARs). In: Rudrapal M, Egbuna C (eds) Computer aided drug design (CADD): from ligand-based methods to structure-based approaches, 1st edn. Elsevier, Cambridge, p 324
Pang YP, Quiram P, Jelacic T et al (1996) Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer’s disease. J Biol Chem 271:P23646. https://doi.org/10.1074/jbc.271.39.23646
Paterson Y, Englander SW, Roder H (1990) An antibody binding site on cytochrome C defined by hydrogen exchange and two-dimensional NMR. Science 249:755–759. https://doi.org/10.1126/SCIENCE.1697101
Pintacuda G, Otting G (2002) Identification of protein surfaces by NMR measurements with a paramagnetic Gd(III) chelate. J Am Chem Soc 124:372–373. https://doi.org/10.1021/JA016985H/SUPPL_FILE/JA016985H_S1.PDF
Potts RO, Guy RH (1992) Predicting skin permeability. Pharm Res 9:663–669. https://doi.org/10.1023/A:1015810312465
Puthenveetil R, Vinogradova O (2019) Solution NMR: a powerful tool for structural and functional studies of membrane proteins in reconstituted environments. J Biol Chem 294:15914
Ramakrishnan M, Kandimalla KK, Wengenack TM et al (2009) Surface plasmon resonance binding kinetics of Alzheimer’s disease amyloid beta peptide-capturing and plaque-binding monoclonal antibodies. Biochemistry 48:10405–10415. https://doi.org/10.1021/BI900523Q
Record MT, Mazur SJ, Melançon P et al (2003) Double helical DNA: conformations, physical properties, and interactions with ligands. Annu Rev Biochem 50:997–1024. https://doi.org/10.1146/ANNUREV.BI.50.070181.005025
Rees D (2016) Fragment-based Drug Discovery: Lessons and Outlook. Edited by Daniel A. Erlanson and Wolfgang Jahnke; Series Editors: Raimund Mannhold, Hugo Kubinyi, and Gerd Folkers. ChemMedChem 11:1667–1667. https://doi.org/10.1002/CMDC.201600256
Reker D, Rodrigues T, Schneider P, Schneider G (2014) Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus. Proc Natl Acad Sci U S A 111:4067–4072. https://doi.org/10.1073/PNAS.1320001111/SUPPL_FILE/PNAS.201320001SI.PDF
Respondek M, Madl T, Göbl C et al (2007) Mapping the orientation of helices in micelle-bound peptides by paramagnetic relaxation waves. J Am Chem Soc 129:5228–5234. https://doi.org/10.1021/JA069004F/SUPPL_FILE/JA069004FSI20070207_094619.PDF
Ress DC, Congreve M, Murray CW, Carr R (2004) Fragment-based lead discovery. Nat Rev Drug Discov 3:660–672. https://doi.org/10.1038/nrd1467
Reuben J, Leigh JS (1972) Effects of paramagnetic lanthanide shift reagents on the proton magnetic resonance spectra of quinoline and pyridine. J Am Chem Soc 94:2789–2793. https://doi.org/10.1021/JA00763A042/ASSET/JA00763A042.FP.PNG_V03
Romasanta AKS, van der Sijde P, Hellsten I et al (2018) When fragments link: a bibliometric perspective on the development of fragment-based drug discovery. Drug Discov Today 23:1596–1609. https://doi.org/10.1016/J.DRUDIS.2018.05.004
Rudling A, Orro A, Carlsson J (2018) Prediction of ordered water molecules in protein binding sites from molecular dynamics simulations: the impact of ligand binding on hydration networks. J Chem Inf Model 58:350. https://doi.org/10.1021/acs.jcim.7b00520
Ryckmans T, Edwards MP, Horne VA et al (2009) Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis. Bioorg Med Chem Lett 19:4406–4409. https://doi.org/10.1016/J.BMCL.2009.05.062
Sabban S (2011) Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity FcεRI receptor. The University of Sheffield
Saio T, Ogura K, Shimizu K et al (2011) An NMR strategy for fragment-based ligand screening utilizing a paramagnetic lanthanide probe. J Biomol NMR 51:395–408. https://doi.org/10.1007/S10858-011-9566-5/FIGURES/8
Salamon Z, Wang Y, Brown MF et al (1994) Conformational changes in rhodopsin probed by surface plasmon resonance spectroscopy. Biochemistry 33:13706–13711. https://doi.org/10.1021/BI00250A022/ASSET/BI00250A022.FP.PNG_V03
Schuffenhauer A, Ruedisser S, Marzinzik A et al (2005) Library design for fragment based screening. Curr Top Med Chem 5:751–762. https://doi.org/10.2174/1568026054637700
Segalés J, Perdiguero E, Muñoz-Cánoves P (2016) Regulation of muscle stem cell functions: a focus on the p38 MAPK signaling pathway. Front Cell Dev Biol 4:92
Seneci P (2000) Solid-phase synthesis and combinatorial technologies. Wiley-Interscience, New York
Senisterra G, Chau I, Vedadi M (2012) Thermal denaturation assays in chemical biology. Assay Drug Dev Technol 10:128–136. https://doi.org/10.1089/ADT.2011.0390/ASSET/IMAGES/MEDIUM/FIGURE5.GIF
Seth PP, Miyaji A, Jefferson EA et al (2005) SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: Internal ribosome entry site IIA subdomain. J Med Chem 48:7099–7102. https://doi.org/10.1021/JM050815O/SUPPL_FILE/JM050815OSI20050919_010845.PDF
Shaffer L (2020) 15 drugs being tested to treat COVID-19 and how they would work. Nat Med. https://doi.org/10.1038/D41591-020-00019-9
Silvestre HL, Blundell TL, Abell C, Ciulli A (2013) Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery. Proc Natl Acad Sci U S A 110:12984–12989. https://doi.org/10.1073/PNAS.1304045110/SUPPL_FILE/PNAS.201304045SI.PDF
Smith EA, Thomas WD, Kiessling LL, Corn RM (2003) Surface plasmon resonance imaging studies of protein-carbohydrate interactions. J Am Chem Soc 125:6140–6148. https://doi.org/10.1021/JA034165U/SUPPL_FILE/JA034165USI20030318_031755.PDF
Sun H, Zhao L, Peng S, Huang N (2014) Incorporating replacement free energy of binding-site waters in molecular docking. Proteins Struct Funct Bioinforma 82:1765. https://doi.org/10.1002/prot.24530
Sybyl (2001) Sybyl molecular modeling software packages
Takahashi H, Nakanishi T, Kami K et al (2000) A novel NMR method for determining the interfaces of large protein–protein complexes. Nat Struct Biol 73(7):220–223. https://doi.org/10.1038/73331
Tian W, Chen C, Lei X et al (2018) CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res 46:W363–W367. https://doi.org/10.1093/NAR/GKY473
Tiwari PB, Bencheqroun C, Lemus M et al (2021) SPRD: a surface plasmon resonance database of common factors for better experimental planning. BMC Mol Cell Biol 22:17. https://doi.org/10.1186/s12860-021-00354-w
Torres PHM, Sodero ACR, Jofily P, Silva-Jr FP (2019) Key topics in molecular docking for drug design. Int J Mol Sci 20:4574
Vikholm I, Györvary E, Peltonen J (1996) Incorporation of lipid-tagged single-chain antibodies into lipid monolayers and the interaction with antigen. Langmuir 12:3276–3281. https://doi.org/10.1021/LA950949C/ASSET/IMAGES/LARGE/LA950949CF00006.JPEG
Vu H, Pedro L, Mak T et al (2018) Fragment-based screening of a natural product library against 62 potential malaria drug targets employing native mass spectrometry. ACS Infect Dis 4:431–444. https://doi.org/10.1021/ACSINFECDIS.7B00197/ASSET/IMAGES/LARGE/ID-2017-00197K_0009.JPEG
Wang X, Wei X, Thijssen B, LipkinSM DJ et al (2012) Three-dimensional reconstruction of protein networks provides insight into human genetic disease. Nat Biotechnol 30:159–164
Williamson MP (2013) Using chemical shift perturbation to characterise ligand binding. Prog Nucl Magn Reson Spectrosc 73:1–16. https://doi.org/10.1016/J.PNMRS.2013.02.001
Wiseman T, Williston S, Brandts JF, Lin LN (1989) Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal Biochem 179:131–137. https://doi.org/10.1016/0003-2697(89)90213-3
Wolf LK, Gao Y, Georgiadis RM (2007) Kinetic discrimination of sequence-specific DNA-drug binding measured by surface plasmon resonance imaging and comparison to solution-phase measurements. J Am Chem Soc 129:10503–10511. https://doi.org/10.1021/JA072401L/SUPPL_FILE/JA072401LSI20070526_082821.PDF
Xue P, Lu HH, Zhu YY et al (2017) Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors. Bioorganic Med Chem Lett 27:1640. https://doi.org/10.1016/j.bmcl.2017.03.009
Yesudasu V, Pradhan HS, Pandya RJ (2021) Recent progress in surface plasmon resonance based sensors: a comprehensive review. Heliyon 7:e06321
Zsoldos Z (2011) A fragment-based docking engine: EHiTS: exhaustive fragment pose enumeration and matching using surface contact based statistical score. ACS Symp Ser 1076:91
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Oliveira, A.M., Rudrapal, M. (2023). Fragment-Based Drug Design in Lead Discovery. In: Rudrapal, M., Khan, J. (eds) CADD and Informatics in Drug Discovery. Interdisciplinary Biotechnological Advances. Springer, Singapore. https://doi.org/10.1007/978-981-99-1316-9_8
Download citation
DOI: https://doi.org/10.1007/978-981-99-1316-9_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-1315-2
Online ISBN: 978-981-99-1316-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)